NCT01627769

Brief Summary

It is well documented that following thermal burns injury the development of hypertrophic scars and keloid (HSK) ranges between 40 to 90%. on the other hand It is well documented that cryosurgery wounds generally heal with minimal tissue contraction, resulting in good cosmetic results and with minimal complications. The Aim of the study is To specify the burn and cryosurgery blister fluid for proteins, cytokines and cells and To compare between the above data regarding possible proteins, cytokines and cells, in regard to their possible effect on scarring and wound healing. Also to Identify those components which are present only in the cryosurgery blister and which might have an anti-scarring effect and to characterize them biochemically.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 26, 2012

Completed
5 days until next milestone

Study Start

First participant enrolled

July 1, 2012

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

February 16, 2017

Status Verified

February 1, 2017

Enrollment Period

5.9 years

First QC Date

June 22, 2012

Last Update Submit

February 15, 2017

Conditions

Keywords

scarsblisterssecond degree burnscryosurgerykeloid scarshypertrophic scars

Outcome Measures

Primary Outcomes (1)

  • comparison of inflamation cells and proteins (proteomic evaluation) between blisters caused by heat and blisters caused by cryo injury

    the protein evaluation and comparison is achieved by the use of proteomic study which evaluate the quantity of about 700 different proteins in the fluid of the different blisters (heat blisters compared to "cryo" blisters). we also evaluate the differences in quntities between the inflamation cells in each sample.

    at time of sampling.

Study Arms (2)

second degree blisters patients

blister fluids of second degree burns

cryotherapy blisters

blister fluids of cryosurgery wounds

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with second degree burns patients status post cryosurgery treatment for keloid scars with post treatment blisters

You may qualify if:

  • subject agrees to enroll in the research
  • subject provides written authorization for use and disclosure of protected health information
  • subject provides written informed consent
  • subject who suffer a second degree burn with intact blisters from hot water or liquid within 24 hours, and have been admitted to the emergency room at Carmel Medical center
  • subject suffering from keloids and are treated at the Department of Plastic Surgery , Linn Medical Center, by the intralesional cryosurgery method within the last 24 hours and have developed an intact blister

You may not qualify if:

  • subject who has a blister exudate that is culture positive
  • subject who has any signs of infection in and/or around the blister
  • subject with blisters present more then 24 hours (after which samples will not be taken)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carmel Medical Center

Haifa, Haifa District, Israel

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

blister fluid of kryosurgery and second degree burns Following the results of the above study a further extension of the study is progressing in which the identification of the cell population in the blister fluid following intralesional cryosurgery of keloid scars is examined

MeSH Terms

Conditions

BlisterWounds and InjuriesCicatrixKeloidCicatrix, Hypertrophic

Condition Hierarchy (Ancestors)

Skin Diseases, VesiculobullousSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsFibrosisPathologic ProcessesCollagen DiseasesConnective Tissue Diseases

Study Officials

  • yaron har-shai, Md

    carmel medical center- ISRAEL

    PRINCIPAL INVESTIGATOR

Central Study Contacts

yaron har-shai, Md

CONTACT

nir gal or, Md

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 22, 2012

First Posted

June 26, 2012

Study Start

July 1, 2012

Primary Completion

June 1, 2018

Study Completion

July 1, 2018

Last Updated

February 16, 2017

Record last verified: 2017-02

Locations